-
Views
-
Cite
Cite
Carol M. Mason, Elizabeth Dobard, Warren R. Summer, Steve Nelson, Intraportal Lipopolysaccharide Suppresses Pulmonary Antibacterial Defense Mechanisms, The Journal of Infectious Diseases, Volume 176, Issue 5, November 1997, Pages 1293–1302, https://doi.org/10.1086/514125
- Share Icon Share
Abstract
Translocation of enteric bacteria or their components (or both) has been postulated to play a role in precipitating sepsis or the systemic inflammatory response syndrome. To simulate the effects of translocation on pulmonary host defenses, lipopolysaccharide was injected into the portal vein of normal rats that were subsequently challenged by aerosol inoculation with Pseudomonas aeruginosa. Injection of LPS into the portal vein resulted in increased serum tumor necrosis factor (TNF)-α levels and reduction in lung clearance of P. aeruginosa after aerosol challenge. There were corresponding reductions in alveolar neutrophil recruitment, diminished alveolar macrophage phagocytosis and superoxide anion (O-2) production, and diminished lung TNF recovered by bronchoalveolar lavage. Furthermore, prior intravenous injection of recombinant TNF-α reproduced the defective bacterial clearance, the altered recruitment of airspace neutrophils, and the defective alveolar macrophage phagocytosis. Thus, systemic TNF-α is important in altering pulmonary defenses, and this work supports the concept that bacterial translocation may adversely affect host defenses in distant organs.
- pseudomonas aeruginosa
- sepsis
- tumor necrosis factors
- systemic inflammatory response syndrome
- lung
- bronchial lavage
- drug clearance
- aerosols
- bacterial translocation
- defense mechanisms
- enterobacteriaceae
- intravenous injections
- lipopolysaccharides
- macrophages, alveolar
- neutrophil infiltration
- neutrophils
- phagocytosis
- portal vein
- superoxides
- translocation (genetics)
- vaccination
- rats
- host defense
- anti-bacterial agents